Working… Menu

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01148498
Recruitment Status : Completed
First Posted : June 22, 2010
Last Update Posted : September 25, 2012
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2012
Actual Study Completion Date : August 2012
Certification/Extension First Submitted : September 18, 2012